AS Bryden and Sons Holdings Ltd has reported a decline in financial performance for the first quarter of 2026, reflecting a challenging operating environment across several of its key Caribbean markets, according to its unaudited financial statements for the quarter ended March 31, 2026.
The group recorded revenue of US$141.2 million for the three-month period, down from US$150.6 million in the same period last year.
Net profit attributable to shareholders fell sharply to US$67,000 compared to US$3.2 million reported in the first quarter of 2025.
The company also noted that the results were influenced by a combination of external and internal pressures.
Among the most significant factors was the continued impact of increased alcohol duties in T&T, which constrained consumer demand in key product lines.
Additionally, the after-effects of Hurricane Melissa disrupted Jamaica’s hospitality and tourism sectors, contributing to slower recovery in distribution channels tied to those industries.
The group also faced elevated costs associated with its ongoing regional expansion and integration initiatives, stating that while these investments are intended to strengthen long-term growth, they placed additional burden on profitability during the quarter.
“While profitability was below expectations, the quarter also reflected continued investment in strengthening the long-term foundation of the business. Management remained focused on stabilising operations, improving execution, enhancing working capital management and driving greater efficiency across the group’s regional platform,” the company said.
It also noted that gross profit declined to US$39.1 million from US$41.8 million in the prior year, while operating profit dropped to US$3.8 million, less than half of the US$8.8 million recorded in 2025. Despite the downturn, the consumer goods segment remained the largest contributor to overall revenues, though alcohol-related categories in T&T continued to show weakness.
Other segments, however, provided some stability.
The healthcare and industrial divisions remained relatively resilient, helping to cushion the overall performance as the company also continued efforts to rebuild export market presence and enhance the group’s regional distribution network.
Despite lower earnings, AS Bryden maintained a strong balance sheet as stockholders’ equity rose to US$153.1 million at the end of the quarter.
The company also reported improved cash generation, with operating activities producing US$12.1 million, up from US$8.6 million in the prior-year period.
This improvement was attributed to tighter working capital management and stronger operational discipline across several business units.
Looking ahead, the company said it remains focused on delivering improved results for the remainder of the financial year, noting, “While near-term economic and regulatory pressures remain present in certain territories, we believe the underlying fundamentals of the group remain strong.
“Our diversified portfolio, regional footprint, strategic supplier partnerships, and integrated distribution platform position us well to benefit from future growth opportunities across the Caribbean.”
The financials were signed by Bryden chairman, PB Scott, and CEO Richard Pandohie.
